Supriya Lifescience Limited
NSE:SUPRIYA.NS
637.85 (INR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 775.05 | 0 | 749.56 | -1,158.08 | 1,040.41 | -1,575.82 | 852.51 | -1,895.69 | 1,288.51 | -2,339.4 | 1,657.75 | 23.76 | 310.72 | 9.39 |
| Short Term Investments
| 94.56 | 0 | 111.16 | 2,316.16 | 162.47 | 3,151.64 | 787.37 | 3,791.38 | 651.95 | 4,678.8 | 591.55 | 950.112 | 583.713 | 595.252 |
| Cash and Short Term Investments
| 869.61 | 749.56 | 749.56 | 1,158.08 | 1,202.88 | 1,575.82 | 1,639.88 | 1,895.69 | 1,940.46 | 2,339.4 | 2,249.3 | 973.872 | 894.433 | 604.642 |
| Net Receivables
| 1,057.26 | 0 | 1,116.83 | 0 | 853.91 | 0 | 852.13 | 0 | 807 | 0 | 1,152 | 843.92 | 735 | 544.9 |
| Inventory
| 1,079.85 | 0 | 852.49 | 0 | 988.25 | 0 | 1,157.7 | 0 | 1,063.02 | 0 | 923.11 | 884.6 | 724.8 | 617 |
| Other Current Assets
| 2,184.16 | 0 | 1,259.16 | 0 | 1,063.6 | 0 | 999.16 | 0 | 1,126.33 | 0 | 0.03 | 1,341.388 | 1,044.767 | 195.058 |
| Total Current Assets
| 4,133.62 | 749.56 | 3,978.04 | 1,158.08 | 4,108.64 | 1,575.82 | 4,648.87 | 1,895.69 | 4,941.58 | 2,339.4 | 4,975.44 | 3,199.86 | 2,664 | 1,961.6 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 5,226.78 | 0 | 4,573.01 | 0 | 3,730.11 | 0 | 3,280.6 | 0 | 2,620.45 | 0 | 2,316.74 | 1,805.61 | 1,759.16 | 1,576.4 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 26.97 | 0 | 16.56 | 0 | 12.66 | 0 | 11.05 | 0 | 13.11 | 0 | 15.08 | 30.62 | 30.21 | 27.73 |
| Goodwill and Intangible Assets
| 26.97 | 0 | 16.56 | 0 | 12.66 | 0 | 11.06 | 0 | 13.11 | 0 | 15.08 | 30.62 | 30.21 | 27.73 |
| Long Term Investments
| 724.88 | 0 | 637.95 | 0 | 407.06 | 0 | 252.96 | 0 | 0.53 | 0 | -681.11 | -949.582 | -583.183 | 0.53 |
| Tax Assets
| -724.88 | 0 | 0.01 | 0 | 162.47 | 0 | 0 | 0 | 0 | 0 | 721.48 | 954.482 | 588.053 | 0 |
| Other Non-Current Assets
| 736.54 | -749.56 | 6.81 | -1,158.08 | 9.36 | -1,575.82 | 9.28 | -1,895.69 | 41.91 | -2,339.4 | -0.01 | 0.03 | 0.01 | 2.02 |
| Total Non-Current Assets
| 5,990.29 | -749.56 | 5,234.34 | -1,158.08 | 4,321.66 | -1,575.82 | 3,553.9 | -1,895.69 | 2,676 | -2,339.4 | 2,372.18 | 1,841.16 | 1,794.25 | 1,606.68 |
| Total Assets
| 10,123.91 | 0 | 9,212.38 | 0 | 8,430.3 | 0 | 8,202.77 | 0 | 7,617.58 | 0 | 7,347.62 | 5,041.02 | 4,458.25 | 3,568.28 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 624.07 | 0 | 595.69 | 0 | 551.97 | 0 | 642.28 | 0 | 538.26 | 0 | 489.72 | 561.04 | 510.22 | 419.08 |
| Short Term Debt
| 2.91 | 0 | 4.68 | 0 | 5.1 | 0 | 169.79 | 0 | 307.47 | 0 | 221.2 | 709.9 | 701.29 | 584.28 |
| Tax Payables
| 0 | 0 | -26.8 | 0 | 0 | 0 | 45.87 | 0 | 0 | 0 | 0 | 181.36 | 151.85 | 0 |
| Deferred Revenue
| 0 | 0 | 148.68 | 0 | 29.45 | 0 | 16.58 | 0 | 10.43 | 0 | 254.48 | 229.94 | 151.85 | 0 |
| Other Current Liabilities
| -496.65 | 0 | -549 | 0 | -482.64 | 0 | -559 | 0 | -508.5 | 0 | -458.13 | -716.15 | -565.24 | -259.53 |
| Total Current Liabilities
| 754.4 | 0 | 768.94 | 0 | 655.85 | 0 | 957.8 | 0 | 885.92 | 0 | 996.99 | 1,527.13 | 1,460.19 | 1,162.91 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 0 | 0 | 50.2 | 0 | 52.61 | 0 | 54.89 | 0 | 56.7 | 0 | 52.95 | 19.19 | 20.65 | 21.38 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.12 | 0 | 29.31 | 0 | 207.87 | 0 |
| Deferred Tax Liabilities Non-Current
| 240.85 | 0 | 231.52 | 0 | 151.95 | 0 | 136.75 | 0 | 115.4 | 0 | 111.49 | 124.06 | 80.11 | 0 |
| Other Non-Current Liabilities
| 69.78 | -8,153.67 | 8.04 | 0 | 38.16 | 0 | 58.75 | 0 | -0.01 | 0 | 0.01 | 22.01 | 0.01 | 133.31 |
| Total Non-Current Liabilities
| 310.63 | -8,153.67 | 289.76 | 0 | 242.72 | 0 | 250.39 | 0 | 212.21 | 0 | 193.76 | 165.26 | 308.64 | 154.69 |
| Total Liabilities
| 1,065.03 | -8,153.67 | 1,058.7 | 0 | 898.57 | 0 | 1,208.19 | 0 | 1,098.13 | 0 | 1,190.75 | 1,692.39 | 1,768.83 | 1,317.6 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 13.41 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Common Stock
| 160.97 | 0 | 160.97 | 0 | 160.97 | 0 | 160.97 | 0 | 160.97 | 0 | 160.97 | 146.37 | 146.37 | 146.37 |
| Retained Earnings
| 0 | 0 | 6,004.49 | 0 | 0 | 0 | 4,861.62 | 0 | 0 | 0 | 4,011.34 | 3,202.27 | 2,543.05 | 2,104.31 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 8,153.67 | 7,992.7 | 7,531.73 | 7,370.76 | 6,994.58 | -13.41 | 6,519.45 | 6,358.48 | 6,156.88 | -0.01 | -0.01 | 0 | 0 |
| Other Total Stockholders Equity
| 8,897.91 | 0 | -6,004.49 | 0 | 0 | 0 | 1,972 | 0 | 0 | 0 | 1,984.57 | 0.01 | 0 | -2,250.68 |
| Total Shareholders Equity
| 9,058.88 | 8,153.67 | 8,153.67 | 7,531.73 | 7,531.73 | 6,994.58 | 6,994.59 | 6,519.45 | 6,519.45 | 6,156.88 | 6,156.88 | 3,348.64 | 2,689.42 | 2,250.68 |
| Total Equity
| 9,058.88 | 8,153.67 | 8,153.67 | 7,531.73 | 7,531.73 | 6,994.58 | 6,994.59 | 6,519.45 | 6,519.45 | 6,156.88 | 6,156.88 | 3,348.64 | 2,689.42 | 2,250.68 |
| Total Liabilities & Shareholders Equity
| 10,123.91 | 0 | 9,212.38 | 7,531.73 | 8,430.3 | 6,994.58 | 8,202.78 | 6,519.45 | 7,617.58 | 6,156.88 | 7,347.63 | 5,041.03 | 4,458.25 | 3,568.28 |